📢 Product Launch Announcement: Tenfoday 300

We are proud to introduce Tenfoday 300, a high-quality formulation containing Tenofovir Disoproxil Fumarate 300 mg, indicated for the effective management of HIV-1 infection and chronic hepatitis B.
Designed with a strong focus on clinical reliability, patient safety, and treatment efficacy, Tenfoday 300 embodies our commitment to empowering healthcare professionals and enhancing patient outcomes.

🔹 About Tenfoday 300

• Active Ingredient: Tenofovir Disoproxil Fumarate 300 mg
• Therapeutic Class: Antiviral Agent, Nucleotide Reverse Transcriptase Inhibitor (NRTI)
• Primary Indications:
  • In combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients.
  • For the treatment of chronic hepatitis B in adults and children aged 12 years and older.
• Mechanism of Action:
  Tenofovir disoproxil fumarate is a prodrug that is converted to tenofovir in the body, inhibiting the activity of HIV-1 reverse transcriptase and hepatitis B virus polymerase, thereby blocking viral replication.

🔹 Key Features & Benefits

✅ Potent Antiviral Activity

• Provides strong viral suppression for HIV-1 and HBV.

✅ Proven Efficacy and Safety

• Extensively studied in clinical trials and widely recommended in treatment guidelines.

✅ Once-Daily Convenient Dosing

• Simplifies treatment regimens and enhances adherence.

✅ Well-Tolerated Profile

• Demonstrated renal and bone safety with appropriate monitoring.

✅ Trusted Global Standard

• Recognized and utilized in HIV and HBV management worldwide.

🔹 Target Audience

🏥 Hospitals, HIV Care Centers, Infectious Disease Clinics, Hepatology Units

• A key addition to comprehensive antiviral treatment programs.

👨‍⚕️ Infectious Disease Specialists, Hepatologists, Primary Care Physicians

• A reliable choice in first-line and combination therapy strategies.

🧑‍🤝‍🧑 Patients Living with HIV-1 or Chronic Hepatitis B

• Offering new hope for durable viral control and improved long-term health.

🔹 Our Commitment

At Green Apple Pharmaceuticals Private Limited, we are deeply committed to innovating antiviral therapy with products that are scientifically advanced, highly trusted, and patient-centric.
Tenfoday 300 stands as a testament to our mission of enabling healthier lives through quality medicine.

Tenfoday 300 — Strengthening the Global Fight Against HIV and Hepatitis B.

📦 Now Available

For complete prescribing information, clinical resources, or patient support materials, please contact our medical team or visit Tenfoday 300.